Patient Education Sheet Library
Search Results
Melphalan Conditioning for Autologous Transplant
Melphalan is used for conditioning chemotherapy before an autologous stem cell transplant for multiple myeloma…
Treatment Given by InfusionDownloads:
Download (English)Carmustine, Etoposide, Cytarabine, and Melphalan
The combination of carmustine, etoposide, cytarabine, and melphalan (BEAM) is used for conditioning chemotherapy before…
Treatment Given by InfusionDownloads:
Cisplatin and Radiation
The combination of cisplatin and radiation is used for head and neck cancer (H&N), cervical…
Treatment Given by InfusionDownloads:
Palbociclib and Trastuzumab
The combination of palbociclib and trastuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Palbociclib, Trastuzumab, and Pertuzumab
The combination of palbociclib, trastuzumab, and pertuzumab is used for breast cancer.
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Tafasitamab, Rituximab, and Lenalidomide
The combination of tafasitamab, rituximab, and lenalidomide (Tafa-R2) is used for follicular lymphoma (FL).
Treatment Given by Infusion Treatment Given by Injection Treatment Taken by MouthDownloads:
Downloads:
Downloads:
Emapalumab
Emapalumab is used for a rare immune disorder called primary hemophagocytic lymphohistiocytosis (HLH) and HLH…
Treatment Given by InfusionDownloads:
Infliximab
Infliximab is used for immune-related side effects caused by cancer immunotherapy.
Treatment Given by InfusionDownloads:
Popular Searches
PES Review Committee
The Patient Education Sheet (PES) Committee is a multidisciplinary team of oncology professionals who guide the development and review of these important resources. This committee ensures that every PES is accurate, clear, and meaningful for patients and caregivers navigating cancer treatment.
Led by NCODA and supported through collaboration with three leading professional organizations—ACCC, HOPA, and ONS—the committee combines expertise from across the oncology care spectrum. Together, they uphold best practices, promote consistency in patient education, and remain committed to improving outcomes through accessible, patient-centered information.
